Treatment of portal hypertension in patients with HCC in the era of Baveno VII-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of portal hypertension in patients with HCC in the era of Baveno VII

Published:2023-03 Issue:3 Volume:78 Page:658-662
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Thabut Dominique,Kudo Masatoshi^ORCID

Publisher

Elsevier BV

Subject

Hepatology

Reference25 articles.

1. Baveno VII - renewing consensus in portal hypertension;de Franchis;J Hepatol,2022

2. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis;Ripoll;J Hepatol,2009

3. Systemic treatment of hepatocellular carcinoma: an EASL position paper;Bruix;J Hepatol,2021

4. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding;Lang;Am J Gastroenterol,2004

5. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension;de Franchis;J Hepatol,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma—A systematic review and meta-analysis;Indian Journal of Gastroenterology;2024-08-10

2. Progression of portal hypertension after atezolizumab plus bevacizumab for hepatocellular carcinoma-report a case and literature review;Journal of the Formosan Medical Association;2024-08

3. Response to: “Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC”;JHEP Reports;2024-08

4. Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients with Unresectable HCC;Clinical Gastroenterology and Hepatology;2024-07

5. Transjugular Intrahepatic Portosystemic Shunt Is Associated With Better Waitlist Management of Liver Transplant Candidates With Hepatocellular Carcinoma;Transplant International;2024-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3